Exagen Inc. (XGN) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K, dated June 18, 2020, reports on the results of Exagen Inc.'s 2020 Annual Meeting of Stockholders. The company is incorporated in Delaware and its common stock trades on The Nasdaq Global Market under the symbol XGN.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance voting results.
Material Changes and Voting Results
Stockholders voted on two proposals at the Annual Meeting:
- Proposal 1 (Election of Directors): Stockholders elected three Class I directors for a three-year term expiring in 2023.
- Brian Birk: 7,038,015 votes For; 613,176 votes Withheld.
- Tina S. Nova, Ph.D.: 7,087,448 votes For; 563,743 votes Withheld.
- Ebetuel Pallares, Ph.D.: 7,038,230 votes For; 612,961 votes Withheld.
- Proposal 2 (Ratification of Auditors): Stockholders ratified the appointment of BDO USA, LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2020.
- Results: 8,408,077 votes For; 1,023 votes Against; 20 Abstentions.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items.
Key Facts for Investor Verification
- Verify the final composition of the Board of Directors following the election of the three Class I directors.
- Confirm the engagement of BDO USA, LLP as the independent auditor for the fiscal year ending December 31, 2020.
- Review the definitive proxy statement on Schedule 14A (filed April 29, 2020) for detailed biographies of the elected directors and further context on the proposals.